EyeGate Pharmaceuticals, Inc. Gains 30.27%
Wed 12 Aug 20 at 05:30 PM
EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ) rocketted at $5.38, representing a gain of 30.3%. On Tue 11 Aug 20, EYEG:NASDAQ touched a New 2-Week Intraday High of $4.84. The stock got featured on our News Catalysts scanner on Wed 12 Aug 20 at 07:56 AM in the 'BIOTECH' category. From Tue 28 Jul 20, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ)
Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- India Globalization Capital, Inc. (IGC:NYSEMKT), 300.38%
- Biofrontera AG (BFRA:NASDAQ), 50.1%
- Ocean Power Technologies, Inc. (OPTT:NASDAQ), 44.14%
- The Pennant Group, Inc. (PNTG:NASDAQ), 40.67%
- Cellular Biomedicine Group, Inc. (CBMG:NASDAQ), 35.04%
- XPEL, Inc. (XPEL:NASDAQ), 32.91%
- STRATA Skin Sciences, Inc. (SSKN:NASDAQ), 32.79%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 30.27%
- Aemetis, Inc. (AMTX:NASDAQ), 27.97%
- Summer Infant, Inc. (SUMR:NASDAQ), 27.54%